Bausch Health Companies Inc Share Price Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.39B 12.83B 751B | Sales 2025 * | 9.45B 12.92B 757B | Capitalization | 3.19B 4.37B 256B |
---|---|---|---|---|---|
Net income 2024 * | 336M 459M 26.9B | Net income 2025 * | 381M 521M 30.5B | EV / Sales 2024 * | 2.46 x |
Net Debt 2024 * | 19.91B 27.21B 1,593B | Net Debt 2025 * | 18.33B 25.05B 1,467B | EV / Sales 2025 * | 2.28 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
8.46
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 23/05/22 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 31/07/08 |
John Paulson
CHM | Chairman | 68 | 31/05/17 |
Steven Miller
BRD | Director/Board Member | 35 | 16/03/21 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |